Chromosome studies in human leukemia. II. Chronic granulocytic leukemia

scientific article published on 01 November 1961

Chromosome studies in human leukemia. II. Chronic granulocytic leukemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID14480645

P2093author name stringHUNGERFORD DA
NOWELL PC
P. C. NOWELL
D. A. HUNGERFORD
P407language of work or nameEnglishQ1860
P921main subjectchronic myeloid leukemiaQ729735
chromosome abnormalityQ744962
P304page(s)1013-1035
P577publication date1961-11-01
P1433published inJournal of the National Cancer InstituteQ400279
P1476titleChromosome studies in human leukemia. II. Chronic granulocytic leukemia
P478volume27

Reverse relations

cites work (P2860)
Q41582172A complex pattern of chromosome abnormalities in the acute phase of chronic granulocytic leukaemia.
Q34744320A general theory of carcinogenesis
Q41444680A new approach to the evolution of the blastic crisis from chronic myelocytic leukemia: dynamic interplay of cellular alterations and a changing microenvironment
Q71058130A possible explanation for the origin of the Philadelphia chromosome
Q36785029A review of resistance patterns and phenotypic changes in gastrointestinal stromal tumors following imatinib mesylate therapy
Q41317103Action of chloroquine phosphate in rheumatoid arthritis. II. Chromosome damaging effect
Q36344001Analysis of rat hemopoietic cells on the fluorescence-activated cell sorter. II. Isolation of terminal deoxynucleotidyl transferase-positive cells
Q39919786Anomalies of the Small Acrocentric (chromosomes in Human Tumour Cells*
Q70901424Autologous versus homologous culture media in blood cultures from patients with chronic myelogenous leukaemia. Comparison of the cytogenetic pictures
Q76653547CHROMOSOME PREPARATIONS FROM THE INTESTINAL MUCOSA
Q72025624Chemotherapy of autochthonous myeloid leukemias (Chloroleukemias) in Wistar rats
Q36743640Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries
Q70919166Chromosomal studies in chronic myeloic leukemia
Q41517825Chromosome aberrations in leukocytes exposed in vitro to diagnostic levels of x-rays
Q70862817Chromosome breakages in four chronic myeloid leukemia patients
Q35935700Chromosome complement of lymph node cells in Hodgkin's disease
Q36471739Chronic Myeloid Leukaemia: A paradigm for malignancy or just a strange disease?
Q33386690Classification of lymphoid neoplasms: the microscope as a tool for disease discovery
Q36449899Complex mitochondrial DNA in leukemic and normal human myeloid cells
Q37698231Detection of BCR-ABL Positive Cells in an Asymptomatic Patient: A Case Report and Literature Review
Q90644136Detection of Novel Fusion Transcript VTI1A-CFAP46 in Hepatocellular Carcinoma
Q24683696Discovery of the Philadelphia chromosome: a personal perspective
Q42072139Don't Mess with RUNX1.
Q70920911Double Philadelphia chromosome and isochromosome 17 in the terminal phase of chronic myeloid leukemia
Q92409425Epigenetic Reprogramming and Emerging Epigenetic Therapies in CML
Q34532048Expression and activity of Fyn mediate proliferation and blastic features of chronic myelogenous leukemia
Q35650512Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation
Q50098629How is the Ph-like signature being incorporated into ALL therapy?
Q72622697Human peripheral blood in tissue culture and the action of phytohemagglutinin
Q35982752Hypoxia-Like Signatures Induced by BCR-ABL Potentially Alter the Glutamine Uptake for Maintaining Oxidative Phosphorylation
Q92363766Identification of key candidate targets and pathways for the targeted treatment of leukemia stem cells of chronic myelogenous leukemia using bioinformatics analysis
Q40345637Interaction of the seed and the soil
Q37110802Is it important to decipher the heterogeneity of "normal karyotype AML"?
Q36383369Landscape of gene fusions in epithelial cancers: seq and ye shall find
Q38185576Maintaining low BCR-ABL signaling output to restrict CML progression and enable persistence
Q36461888Malignant conversion of cells in vitro by carcinogens and viruses
Q28076328Modeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft Models
Q49914671Modeling the human bone marrow niche in mice: From host bone marrow engraftment to bioengineering approaches
Q35939340Multiple myeloma superimposed on chronic myelocytic leukemia
Q41561881Pure red cell hypoplasia associated with long-arm deletion of chromosome 5
Q30276545Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer
Q37194503Recurrent gene fusions in prostate cancer
Q26851525Recurrent rearrangements in prostate cancer: causes and therapeutic potential
Q40002580Regulatory mechanisms acting on hemopoietic stem cells. Some clinical implications.
Q42339101SOCS1 function in BCR-ABL mediated myeloproliferative disease is dependent on the cytokine environment
Q36214189Sequencing Strategies to Guide Decision Making in Cancer Treatment.
Q38926441Somatic Engineering of Oncogenic Chromosomal Rearrangements: A Perspective
Q34523506Successful pregnancy in a patient with chronic myeloid leukaemia exposed to dasatinib during the first trimester
Q30396342The Microscope as a Tool for Disease Discovery-A Personal Voyage
Q34193206The new biomedical technology.
Q39551053The non-coding oncogene: a case of missing DNA evidence?
Q38097382The war on cancer: are we winning?
Q41093037Transcriptome profiling identifies a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma
Q36395595Transformation induced by simian virus 40 in human renal cell cultures. I. Morphology and growth characteristics
Q35694365Translating cancer 'omics' to improved outcomes
Q43248935Translational research: are we on the right track? 2008 American Society for Clinical Investigation Presidential Address
Q37363960Translocations in epithelial cancers
Q38734590Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors
Q37806625Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences
Q93481901Trio receives Lasker Foundation Clinical Award for breakthroughs in leukemia treatment
Q30480984Using Bcr-Abl to examine mechanisms by which abl kinase regulates morphogenesis in Drosophila.
Q52759227Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors.
Q53829916[DNA (Feulgen) and chromosome studies in mongolism with acute leukemia].
Q54123354gDNA qPCR is statistically more reliable than mRNA analysis in detecting leukemic cells to monitor CML.

Search more.